Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Participants - All

Participant search result

CEO & CO-FOUNDER

Tulsa, OK, United States

SphereBio 

Redefining how vaccines work

Redefining how vaccines work

Representative Europe

Berlin, Germany, United States

Minnesota Trade Office 

As Minnesota Trade Office European Representative, I connect European innovators to the Minnesota lifescience ecosystem and state support resources.

As Minnesota Trade Office European Representative, I connect European innovators to the Minnesota lifescience ecosystem and state support resources.

Sr. International Trade Manager, North Carolina

Raleigh, United States

Economic Development Parnership of North Carolina (EDPNC), USA 

CEO/Founder

Durham (RTP), North Carolina, United States

Jericho Sciences 

Developing novel antivirals to address public health unmet needs to clear chronic infections and prepare for potential emerging viruses.

Developing novel antivirals to address public health unmet needs to clear chronic infections and prepare for potential emerging viruses.

Director of Drug Discovery Strategy

Cambridge, United States

Kissei America, Inc. 

NIRSense makes novel tissue perfusion sensors capable of working across populations in any environment. We seek life science research use cases and partners.

NIRSense makes novel tissue perfusion sensors capable of working across populations in any environment. We seek life science research use cases and partners.

Co-founder, CEO

Doylestown, United States

HO2Rx 

At Ho2Rx we pioneer a game-changing therapy to safely and durably treat intractable chronic inflammatory diseases by targeting inflammation-damaged tissues.

At Ho2Rx we pioneer a game-changing therapy to safely and durably treat intractable chronic inflammatory diseases by targeting inflammation-damaged tissues.

Project and Business Development Manager

Charlotte, United States

Tanner Pharma 

Manage global clinical supply projects for pharma, biotech and CROs, ensuring compliant sourcing, logistics and delivery while driving growth and partnerships.

Manage global clinical supply projects for pharma, biotech and CROs, ensuring compliant sourcing, logistics and delivery while driving growth and partnerships.

Director of Sales Strategy and Business Development

Charlotte, United States

Tanner Pharma 

Enabling emerging biopharma to turn promising therapies into patient impact through compliant global access, clinical supply, and expert operational support.

Enabling emerging biopharma to turn promising therapies into patient impact through compliant global access, clinical supply, and expert operational support.

Director, Business Development

Morrisville, United States

Economic Development Parnership of North Carolina (EDPNC), USA 

Kymanox is a professional services company with expertise in drug and device development from early clinical to commercialization.

Kymanox is a professional services company with expertise in drug and device development from early clinical to commercialization.

Lead Innovation Economist

Washington, United States

World Bank Group 

Supporting acceleration and scaling of innovations for development

Supporting acceleration and scaling of innovations for development

Executive Director

Portland, United States

Oregon Life Sciences 

Executive Director, Oregon Life Sciences. Building global life science industry partnerships to drive innovation and biomanufacturing growth in Oregon.

Executive Director, Oregon Life Sciences. Building global life science industry partnerships to drive innovation and biomanufacturing growth in Oregon.

COO

Raleigh, United States

iORGANBIO 

At iOrganBio, We use rapid throughput single cell transcriptomics to digitize the biology of cells and leverages advanced robotics and AI to guide the differentiation of stem cells into organoids and NAMs.

At iOrganBio, We use rapid throughput single cell transcriptomics to digitize the biology of cells and leverages advanced robotics and AI to guide the differentiation of stem cells into organoids and NAMs.

Physician executive, serial drug development entrepreneur who ideates health innovations and then brokers them to significant medical adoptions: aligning the vision, culture, and strategy, building elite teams, and recruiting high quality capital.

Physician executive, serial drug development entrepreneur who ideates health innovations and then brokers them to significant medical adoptions: aligning the vision, culture, and strategy, building elite teams, and recruiting high quality capital.

Director of Research and Development

Portland, United States

Caravel Bio 

Highly motivated R&D leader with over 10 years of experience in natural product biosynthesis, synthetic biology and enzyme discovery. Proven track record in project delivery, leading cross-functional teams and fostering a culture of innovation.

Highly motivated R&D leader with over 10 years of experience in natural product biosynthesis, synthetic biology and enzyme discovery. Proven track record in project delivery, leading cross-functional teams and fostering a culture of innovation.

Senior Director, OHSUTechnology Transfer,

Portland, United States

Oregon Health & Science University 

I'm a technology transfer professional with startup and economic development expertise. I serve on the Board of Directors for Oregon Life Sciences and Oregon Nanoscience and Microtechnologies Institute where I represent Oregon's bioscience community.

I'm a technology transfer professional with startup and economic development expertise. I serve on the Board of Directors for Oregon Life Sciences and Oregon Nanoscience and Microtechnologies Institute where I represent Oregon's bioscience community.

Founder & CEO

Berkeley, United States

Jungle Biolabs 

We offer ultra-tight, highly inducible expression systems for prokaryotes — enabling rapid transitions from R&D to manufacturing with high yields & low costs.

We offer ultra-tight, highly inducible expression systems for prokaryotes — enabling rapid transitions from R&D to manufacturing with high yields & low costs.

17 results

Countries

Organisation Types

Areas of Activity

What is your business/industry sector?